Lawrence Helson,George M. Shopp,Annie Bouchard,Muhammed Majeed
申请号：
US16561195
公开号：
US20190388422A1
申请日:
2019.09.05
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention includes compositions and methods for preventing one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by an active agent or a drug in a human or animal subject comprising: an amount of a lysophosphatidylglycerol adapted for oral administration effective to reduce or prevent one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by the active agent or drug.
